The flavonoid of Dracocephalum heterophyllum Benth. ameliorates cerebral small vessel disease by inhibiting the autophagy via Angs-Tie2 signaling pathway
BackgroundCerebral small vessel disease (CSVD) is a common cause of stroke and vascular cognitive impairment. It is urgent to find drugs targeting CSVD. This study explores the therapeutic potential of the flavonoid (DHBF) derived from Dracocephalum heterophyllum Benth., a traditional Tibetan medici...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1500307/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850273735587659776 |
|---|---|
| author | Lin Liu Wen He Wen He Sijing Liu Yang Li Peng Wang Fang Yan Wenjing Yang Yongxue Yang Jinlin Guo |
| author_facet | Lin Liu Wen He Wen He Sijing Liu Yang Li Peng Wang Fang Yan Wenjing Yang Yongxue Yang Jinlin Guo |
| author_sort | Lin Liu |
| collection | DOAJ |
| description | BackgroundCerebral small vessel disease (CSVD) is a common cause of stroke and vascular cognitive impairment. It is urgent to find drugs targeting CSVD. This study explores the therapeutic potential of the flavonoid (DHBF) derived from Dracocephalum heterophyllum Benth., a traditional Tibetan medicine used for cardiovascular diseases, in treating CSVD and its underlying mechanisms.MethodsSpontaneously hypertensive rats (24-weeks-old) were treated with DHBF for 8 weeks. The Morris water maze test, laser speckle contrast imaging, photoacoustic tomography, HE and Nissl staining were used to evaluate the effect of DHBF in CSVD rats. Network pharmacology and UPLC-MS were used to identify DHBF components and potential mechanisms. Human umbilical vein endothelial cells (HUVECs) were exposed to 10% O2 to mimic CSVD conditions, and the effects of DHBF on proliferation, migration, and autophagy were evaluated. The expression levels of Angs, Tie2, LC3-Ⅱ/Ⅰ and p62 were detected by qRT-PCR and WB analyses. Molecular docking and lentivirus-mediated Ang2 knockdown/overexpression were performed to validate DHBF’s targeting of Ang2.ResultsDHBF alleviated vessel injury, improved learning and memory abilities, and increased cerebral blood perfusion and oxygen supply capacity in 24-week-old CSVD rats (p < 0.05). A total of 31 components of DHBF were identified by UPLC-Q-Orbitrap HRMS. Results indicated that DHBF alleviated CSVD by promoting cell proliferation, migration and invasion while inhibiting autophagy in endothelial cell. This regulation was associated with alterations in the Angs-Tie2 pathway and its downstream proteins, including decreased levels of Ang2, Tie2, LC3-Ⅱ/LC3-Ⅰ and increased the levels of Ang1 and p62 (p < 0.05). Knocking down Ang2 showed regulatory effects similar to those observed with DHBF intervention, while overexpression of Ang2 showed opposite effects. In addition, Ang2 overexpression attenuated the regulatory effects of DHBF on Angs-Tie2 pathways and autophagy in HUVECs. These results demonstrated that DHBF alleviated CSVD via inhibiting Ang2, which might be related to danshensu, lonicerin, 8-hydroxyquinoline, esculetin, isophorone, and ethyl caffeate.ConclusionIn summary, DHBF exerts a therapeutic effect on CSVD by inhibiting Ang2, regulating the Angs-Tie2 pathway, and inhibiting endothelial autophagy. This study proposed a potential effective target for CSVD, provided data to support subsequent drug development for this condition. |
| format | Article |
| id | doaj-art-276f5994bd474d79954443ffcfd7c2d0 |
| institution | OA Journals |
| issn | 1663-9812 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj-art-276f5994bd474d79954443ffcfd7c2d02025-08-20T01:51:23ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-05-011610.3389/fphar.2025.15003071500307The flavonoid of Dracocephalum heterophyllum Benth. ameliorates cerebral small vessel disease by inhibiting the autophagy via Angs-Tie2 signaling pathwayLin Liu0Wen He1Wen He2Sijing Liu3Yang Li4Peng Wang5Fang Yan6Wenjing Yang7Yongxue Yang8Jinlin Guo9College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaCollege of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaGeriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Department of Clinical Trial Center, Chengdu Fifth People’s Hospital (The Second Clinical Medical College, Affiliated Fifth People’s Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, ChinaCollege of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaCollege of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaGeriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Department of Clinical Trial Center, Chengdu Fifth People’s Hospital (The Second Clinical Medical College, Affiliated Fifth People’s Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, ChinaGeriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Department of Clinical Trial Center, Chengdu Fifth People’s Hospital (The Second Clinical Medical College, Affiliated Fifth People’s Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, ChinaCollege of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaGeriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Department of Clinical Trial Center, Chengdu Fifth People’s Hospital (The Second Clinical Medical College, Affiliated Fifth People’s Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, ChinaCollege of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaBackgroundCerebral small vessel disease (CSVD) is a common cause of stroke and vascular cognitive impairment. It is urgent to find drugs targeting CSVD. This study explores the therapeutic potential of the flavonoid (DHBF) derived from Dracocephalum heterophyllum Benth., a traditional Tibetan medicine used for cardiovascular diseases, in treating CSVD and its underlying mechanisms.MethodsSpontaneously hypertensive rats (24-weeks-old) were treated with DHBF for 8 weeks. The Morris water maze test, laser speckle contrast imaging, photoacoustic tomography, HE and Nissl staining were used to evaluate the effect of DHBF in CSVD rats. Network pharmacology and UPLC-MS were used to identify DHBF components and potential mechanisms. Human umbilical vein endothelial cells (HUVECs) were exposed to 10% O2 to mimic CSVD conditions, and the effects of DHBF on proliferation, migration, and autophagy were evaluated. The expression levels of Angs, Tie2, LC3-Ⅱ/Ⅰ and p62 were detected by qRT-PCR and WB analyses. Molecular docking and lentivirus-mediated Ang2 knockdown/overexpression were performed to validate DHBF’s targeting of Ang2.ResultsDHBF alleviated vessel injury, improved learning and memory abilities, and increased cerebral blood perfusion and oxygen supply capacity in 24-week-old CSVD rats (p < 0.05). A total of 31 components of DHBF were identified by UPLC-Q-Orbitrap HRMS. Results indicated that DHBF alleviated CSVD by promoting cell proliferation, migration and invasion while inhibiting autophagy in endothelial cell. This regulation was associated with alterations in the Angs-Tie2 pathway and its downstream proteins, including decreased levels of Ang2, Tie2, LC3-Ⅱ/LC3-Ⅰ and increased the levels of Ang1 and p62 (p < 0.05). Knocking down Ang2 showed regulatory effects similar to those observed with DHBF intervention, while overexpression of Ang2 showed opposite effects. In addition, Ang2 overexpression attenuated the regulatory effects of DHBF on Angs-Tie2 pathways and autophagy in HUVECs. These results demonstrated that DHBF alleviated CSVD via inhibiting Ang2, which might be related to danshensu, lonicerin, 8-hydroxyquinoline, esculetin, isophorone, and ethyl caffeate.ConclusionIn summary, DHBF exerts a therapeutic effect on CSVD by inhibiting Ang2, regulating the Angs-Tie2 pathway, and inhibiting endothelial autophagy. This study proposed a potential effective target for CSVD, provided data to support subsequent drug development for this condition.https://www.frontiersin.org/articles/10.3389/fphar.2025.1500307/fullflavonoid of Dracocephalum heterophyllum Benth.human umbilical vein endothelial cellscerebral small vessel diseaseAngiogeninautophagy |
| spellingShingle | Lin Liu Wen He Wen He Sijing Liu Yang Li Peng Wang Fang Yan Wenjing Yang Yongxue Yang Jinlin Guo The flavonoid of Dracocephalum heterophyllum Benth. ameliorates cerebral small vessel disease by inhibiting the autophagy via Angs-Tie2 signaling pathway Frontiers in Pharmacology flavonoid of Dracocephalum heterophyllum Benth. human umbilical vein endothelial cells cerebral small vessel disease Angiogenin autophagy |
| title | The flavonoid of Dracocephalum heterophyllum Benth. ameliorates cerebral small vessel disease by inhibiting the autophagy via Angs-Tie2 signaling pathway |
| title_full | The flavonoid of Dracocephalum heterophyllum Benth. ameliorates cerebral small vessel disease by inhibiting the autophagy via Angs-Tie2 signaling pathway |
| title_fullStr | The flavonoid of Dracocephalum heterophyllum Benth. ameliorates cerebral small vessel disease by inhibiting the autophagy via Angs-Tie2 signaling pathway |
| title_full_unstemmed | The flavonoid of Dracocephalum heterophyllum Benth. ameliorates cerebral small vessel disease by inhibiting the autophagy via Angs-Tie2 signaling pathway |
| title_short | The flavonoid of Dracocephalum heterophyllum Benth. ameliorates cerebral small vessel disease by inhibiting the autophagy via Angs-Tie2 signaling pathway |
| title_sort | flavonoid of dracocephalum heterophyllum benth ameliorates cerebral small vessel disease by inhibiting the autophagy via angs tie2 signaling pathway |
| topic | flavonoid of Dracocephalum heterophyllum Benth. human umbilical vein endothelial cells cerebral small vessel disease Angiogenin autophagy |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2025.1500307/full |
| work_keys_str_mv | AT linliu theflavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT wenhe theflavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT wenhe theflavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT sijingliu theflavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT yangli theflavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT pengwang theflavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT fangyan theflavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT wenjingyang theflavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT yongxueyang theflavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT jinlinguo theflavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT linliu flavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT wenhe flavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT wenhe flavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT sijingliu flavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT yangli flavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT pengwang flavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT fangyan flavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT wenjingyang flavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT yongxueyang flavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway AT jinlinguo flavonoidofdracocephalumheterophyllumbenthamelioratescerebralsmallvesseldiseasebyinhibitingtheautophagyviaangstie2signalingpathway |